Ibrutinib for Early-Stage Chronic Lymphocytic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial
J. Clin. Oncol 2024 Nov 27;[EPub Ahead of Print], P Langerbeins, S Robrecht, P Nieper, P Cramer, M Fürstenau, O Al-Sawaf, F Simon, AM Fink, KA Kreuzer, U Vehling-Kaiser, E Tausch, C Schneider, L Müller, MJ Eckart, R Schlag, W Freier, T Gaska, C Balser, M Reiser, M Stauch, MO Zahn, S Dörfel, P Staib, T Behlendorf, M Hensel, H Hebart, H Klaproth, A Block, R Liersch, U Hauch, B Heinrich, CM Wendtner, K Fischer, S Stilgenbauer, B Eichhorst, M HallekFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.